Effects of rapid tryptophan depletion on brain 5-HT2 receptors:: a PET study

被引:69
作者
Yatham, LN [1 ]
Liddle, PF
Shiah, IS
Lam, RW
Adam, MJ
Zis, AP
Ruth, TJ
机构
[1] Univ British Columbia, Div Mood Disorders, Vancouver, BC V5Z 1M9, Canada
[2] Univ British Columbia, Div Schizophrenia, Vancouver, BC V5Z 1M9, Canada
[3] Univ British Columbia, TRIUMF Positron Emiss Tomog Programme, Vancouver, BC V5Z 1M9, Canada
[4] Tri Serv Gen Hosp, Dept Psychiat, Natl Dev Med Ctr, Taipei, Taiwan
关键词
D O I
10.1192/bjp.178.5.448
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background The mechanism by which rapid tryptophan depletion (RTD) paradigm induces depressive relapse in recently remitted patients with depression is unknown. Aims To determine the effects of RTD on brain 5-HT2 receptors using positron emission tomography (PET) and F-18-labelled setoperone. Method Ten healthy women underwent two PET scans. Each scan was done 5 h after the ingestion of either a balanced or a tryptophan-deficient amino acid mixture, and the two test sessions were separated by at least 5 days. Results The RTD decreased plasma free tryptophan levels significantly but it had no significant effects on mood. Subjects showed a significant decrease in brain 5-HT2 receptor binding in various cortical regions following the RTD session. Conclusions When taken with the evidence that antidepressant treatment is associated with a decrease in brain 5-HT2 receptors. these findings suggest that a decrease in 5-HT2 binding following RTD might be an adaptive response that provides protection against depressive symptoms. Declaration of interest None.
引用
收藏
页码:448 / 453
页数:6
相关论文
共 35 条
  • [1] Adam M. J., 1997, Journal of Labelled Compounds and Radiopharmaceuticals, V40, P258
  • [2] ANDERSON GM, 1981, CLIN CHEM, V27, P775
  • [3] BLACKSHEAR MA, 1982, J PHARMACOL EXP THER, V221, P303
  • [4] A METHOD FOR THE INVIVO INVESTIGATION OF THE SEROTONERGIC 5-HT2 RECEPTORS IN THE HUMAN CEREBRAL-CORTEX USING POSITRON EMISSION TOMOGRAPHY AND F-18 LABELED SETOPERONE
    BLIN, J
    SETTE, G
    FIORELLI, M
    BLETRY, O
    ELGHOZI, JL
    CROUZEL, C
    BARON, JC
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 54 (05) : 1744 - 1754
  • [5] Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
    Breier, A
    Su, TP
    Saunders, R
    Carson, RE
    Kolachana, BS
    de Bartolomeis, A
    Weinberger, DR
    Weisenfeld, N
    Malhotra, AK
    Eckelman, WC
    Pickar, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) : 2569 - 2574
  • [6] Bremner JD, 1997, ARCH GEN PSYCHIAT, V54, P364
  • [7] REGIONAL CENTRAL SEROTONIN-2 RECEPTOR-BINDING AND PHOSPHOINOSITIDE TURNOVER IN RATS WITH 5,7-DIHYDROXYTRYPTAMINE LESIONS
    BUTLER, PD
    PRANZATELLI, MR
    BARKAI, AI
    [J]. BRAIN RESEARCH BULLETIN, 1990, 24 (01) : 125 - 129
  • [8] EFFECTS OF CHRONIC ORAL-ADMINISTRATION OF THE ANTIDEPRESSANTS, DESMETHYLIMIPRAMINE AND ZIMELIDINE ON RAT CORTICAL GABAB BINDING-SITES - A COMPARISON WITH 5-HT2 BINDING-SITE CHANGES
    CROSS, JA
    HORTON, RW
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (02) : 331 - 336
  • [9] LABELING OF A SEROTONINERGIC LIGAND WITH F-18 - [F-18] SETOPERONE
    CROUZEL, C
    VENET, M
    IRIE, T
    SANZ, G
    BOULLAIS, C
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1988, 25 (04) : 403 - 414
  • [10] Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: Implications for the role of serotonin in the mechanism of antidepressant action
    Delgado, PL
    Miller, HL
    Salomon, RM
    Licinio, J
    Krystal, JH
    Moreno, FA
    Heninger, GR
    Charney, DS
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 46 (02) : 212 - 220